Studies have shown that all 15 GLP-1 medications significantly reduce HbA1c and fasting blood glucose levels compared to placebo
Loss of Appetite Although appetite suppression is desired to promote weight loss, it may result in: Skipping meals unintentionally Low energy levels Nutritional deficiencies, if not monitored properly A proper diet becomes essential during GLP-1 treatment
Often this requires extraordinary financial investment in case costs and limitless hours of hard work to make sure no client gets less than they deserve
Screening for nondiabetic kidney disease Careful consideration should be given to nondiabetic causes of CKD, particularly in patients with rapidly increasing albuminuria or decreasing eGFR
J Am Coll Cardiol 70(16):20222035 Saglietto A, Falasconi G, Penela D, Francia P, Sau A, Ng FS et al (2024) Glucagon-like peptide-1 receptor agonist semaglutide reduces atrial fibrillation incidence: a systematic review and meta-analysis